Success for a new Generation of Basic Therapeutics The Janus-Kinase -Inhibitor Baricitinib in rheumatoid Arthritis

被引：0
|
作者：
Keysser, G. [1 ]
机构：
[1] Univ Klinikum Halle, Klin Innere Med 2, Dept Innere Med, Ernst Grube Str 40, D-06097 Halle, Saale, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2017年 / 76卷 / 05期
关键词：
D O I：
10.1007/s00393-017-0307-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：461 / 462
页数：2
相关论文
共 50 条
  • [31] Synthesis and Characterization of Compounds Potentially Related to the Janus Kinase Inhibitor Baricitinib
    Dasari, S. R.
    Seelam, N.
    Jayachandra, S.
    Vadali, L. R.
    Yerva, E. R.
    Tondepu, S.
    Gadakar, M. K.
    RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2019, 55 (10) : 1569 - 1574
  • [32] Janus kinase inhibitors for the treatment of rheumatoid arthritis
    Jang, Sun Hee
    Ju, Ji Hyeon
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (02): : 105 - 108
  • [33] Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (04) : 306 - 312
  • [34] Efficacy of Janus kinase inhibitors in rheumatoid arthritis
    Camille Langbour
    Jessica Rene
    Philippe Goupille
    Guillermo Carvajal Alegria
    Inflammation Research, 2023, 72 : 1121 - 1132
  • [35] A case of widespread molluscum contagiosum caused by baricitinib, a Janus kinase inhibitor
    Wong, Gwyneth Natalie
    Lee, Senhong
    Foley, Peter
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 (04) : E334 - +
  • [36] Efficacy of Janus kinase inhibitors in rheumatoid arthritis
    Langbour, Camille
    Rene, Jessica
    Goupille, Philippe
    Alegria, Guillermo Carvajal
    INFLAMMATION RESEARCH, 2023, 72 (05) : 1121 - 1132
  • [37] Synthesis and Characterization of Compounds Potentially Related to the Janus Kinase Inhibitor Baricitinib
    S. R. Dasari
    N. Seelam
    S. Jayachandra
    L. R. Vadali
    E. R. Yerva
    S. Tondepu
    M. K. Gadakar
    Russian Journal of Organic Chemistry, 2019, 55 : 1569 - 1574
  • [38] New therapeutics in rheumatoid arthritis
    Savage, C
    St Clair, EW
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2006, 32 (01) : 57 - +
  • [39] Effects Of Tofacitinib, An Oral Janus Kinase Inhibitor, On Work Limitations In Patients With Rheumatoid Arthritis
    Strand, Vibeke
    Kanik, Keith S.
    Connell, Carol
    Wilkinson, Bethanie
    Gruben, David
    Wallenstein, Gene
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1002 - S1002
  • [40] ARE THERE ANY ETHNIC DIFFERENCES IN THE RESPONSE TO JANUS KINASE INHIBITOR THERAPY FOR THE TREATMENT OF RHEUMATOID ARTHRITIS?
    Jubber, Ameen
    Hussain, Wajith H. Z.
    Moorthy, Arumugam
    RHEUMATOLOGY, 2022, 61
12345